Article info

Download PDFPDF

Response after treatment with pembrolizumab in a patient with myelophthisis due to melanoma: the role of checkpoint inhibition in the bone

Authors

  1. a Samuel.rosner{at}med.einstein.yu.edu
  2. b senf{at}mskcc.org
  3. c PostowM{at}mskcc.org
View Full Text

Citation

Rosner S, Sen F, Postow M
Response after treatment with pembrolizumab in a patient with myelophthisis due to melanoma: the role of checkpoint inhibition in the bone

Publication history

  • Received January 20, 2017
  • Accepted March 24, 2017
  • First published April 18, 2017.
Online issue publication 
April 18, 2017

Request permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.